Volitionrx (VNRX) EBIAT (2019 - 2025)
Historic EBIAT for Volitionrx (VNRX) over the last 9 years, with Q3 2025 value amounting to -$5.4 million.
- Volitionrx's EBIAT rose 781.77% to -$5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$23.1 million, marking a year-over-year increase of 2365.11%. This contributed to the annual value of -$27.3 million for FY2024, which is 2359.8% up from last year.
- Volitionrx's EBIAT amounted to -$5.4 million in Q3 2025, which was up 781.77% from -$6.3 million recorded in Q2 2025.
- Volitionrx's 5-year EBIAT high stood at $137.0 million for Q4 2021, and its period low was -$9.6 million during Q2 2023.
- Over the past 5 years, Volitionrx's median EBIAT value was -$7.1 million (recorded in 2024), while the average stood at $779721.5.
- In the last 5 years, Volitionrx's EBIAT surged by 57594171.05% in 2021 and then crashed by 945222.97% in 2023.
- Over the past 5 years, Volitionrx's EBIAT (Quarter) stood at $137.0 million in 2021, then plummeted by 99.93% to $94092.0 in 2022, then plummeted by 9452.23% to -$8.8 million in 2023, then soared by 33.44% to -$5.9 million in 2024, then grew by 7.64% to -$5.4 million in 2025.
- Its EBIAT was -$5.4 million in Q3 2025, compared to -$6.3 million in Q2 2025 and -$5.5 million in Q1 2025.